Emterra Pharma

Emterra Pharma is a biopharmaceutical company focused on the development of novel cannabinoid-based therapeutics. The company leverages its expertise in medicinal chemistry to design and optimize small molecule candidates that target the endocannabinoid system for the treatment of pain, inflammation, and various neurological conditions. Emterra Pharma aims to address significant unmet medical needs by creating highly selective and potent compounds with improved safety profiles compared to existing treatments. Their research and development efforts are primarily centered on early-stage discovery and pre-clinical validation of their lead candidates.